ID: ALA2303859

Max Phase: Preclinical

Molecular Formula: C16H29NO11

Molecular Weight: 411.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC[C@@H]1O[C@@H](OC)[C@@H](NC(C)=O)[C@@H](O)[C@@H]1O[C@@H]1O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C16H29NO11/c1-6(19)17-9-11(21)14(8(5-24-2)27-15(9)25-3)28-16-13(23)12(22)10(20)7(4-18)26-16/h7-16,18,20-23H,4-5H2,1-3H3,(H,17,19)/t7-,8-,9-,10-,11+,12-,13-,14+,15+,16-/m0/s1

Standard InChI Key:  PPECGRUIPSBHLB-SVTOHCLSSA-N

Associated Targets(Human)

Fucosyltransferase 4 41 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 411.40Molecular Weight (Monoisotopic): 411.1741AlogP: -3.95#Rotatable Bonds: 7
Polar Surface Area: 176.40Molecular Species: NEUTRALHBA: 11HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.94CX Basic pKa: CX LogP: -3.71CX LogD: -3.71
Aromatic Rings: 0Heavy Atoms: 28QED Weighted: 0.24Np Likeness Score: 1.65

References

1. Galan MC, Dodson CS, Venot AP, Boons GJ..  (2004)  Glycosyltransferase activity can be selectively modulated by chemical modifications of acceptor substrates.,  14  (9): [PMID:15081009] [10.1016/j.bmcl.2004.02.024]

Source